Skip to main content
SpringerLink
Log in

Reference Datasets for Bioequivalence Trials in a Two-Group Parallel Design

  • Research Article
  • Published:
The AAPS Journal Aims and scope Submit manuscript

Abstract

In order to help companies qualify and validate the software used to evaluate bioequivalence trials with two parallel treatment groups, this work aims to define datasets with known results. This paper puts a total 11 datasets into the public domain along with proposed consensus obtained via evaluations from six different software packages (R, SAS, WinNonlin, OpenOffice Calc, Kinetica, EquivTest). Insofar as possible, datasets were evaluated with and without the assumption of equal variances for the construction of a 90% confidence interval. Not all software packages provide functionality for the assumption of unequal variances (EquivTest, Kinetica), and not all packages can handle datasets with more than 1000 subjects per group (WinNonlin). Where results could be obtained across all packages, one showed questionable results when datasets contained unequal group sizes (Kinetica). A proposal is made for the results that should be used as validation targets.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. European Medicines Agency, Committee for Human Medicinal Products. Guideline on the investigation of bioequivalence. CPMP/EWP/QWP/1401/98 Rev. 1/ Corr. 2010.

  2. US Food and Drug Administration. Bioavailability and bioequivalence studies for orally administered drug products—general considerations. Revision 1. 2003.

  3. World Health Organization. Multisource (generic) pharmaceutical products: guidelines on registration requirements to establish interchangeability. In: Fortieth report of the WHO Expert Committee on Specifications for Pharmaceutical Preparations. Geneva, World Health Organization. WHO Technical Report Series, No. 937, Annex 7. 2006.

  4. Health Canada, Therapeutic Products Directorate. Conduct and analysis of comparative bioavailability studies. 2012.

  5. Schütz H, Labes D, Fuglsang A. Reference datasets for 2-treatment, 2-sequence, 2-period bioequivalence studies. The AAPS J. 2014;16:1292–7. doi:10.1208/s12248-014-9661-0.

    Article  Google Scholar 

  6. Clayton D, Leslie A. The bioavailability of erythromycin stearate versus enteric-coated erythromycin base when taken immediately before and after food. J Int Med Res. 1981;9:470–7. doi:10.1177/030006058100900608.

    CAS  PubMed  Google Scholar 

  7. European Medicines Agency, Committee for Medicinal Products for Human Use. Guideline on the requirements for clinical documentation for orally inhaled products (OIP) including the requirements for demonstration of therapeutic equivalence between two inhaled products for use in the treatment of asthma and chronic obstructive pulmonary disease (COPD) in adults and for use in the treatment of asthma in children and adolescents. CPMP/EWP/4151/00 Rev.1. 2009.

  8. Bolton S and Bon C. Statistical consideration: alternate designs and approaches for bioequivalence assessments. In: Kanfer I and Shargel L, editors. Generic Drug Product Development. Bioequivalence Issues. New York: Informa Healthcare; 2008. p. 123–141.

  9. Hughes L, Adjusting for Unequal Variances in WNL Bioeq. Certara Forums, Phoenix WNL Basics, 1 July 2013 http://www.certara.com/forums/topic/453-adjusting-for-unequal-variances-in-wnl-bioeq/ accessed 5 November 2014; free registration required

  10. Anon. Phoenix WinNonlin 6.4 User’s Guide, Pharsight 2014, p. 86.

  11. Wang H, Chow S-C. A practical approach for comparing means of two groups without equal variance assumption. Statist Med. 2002;21:3137–51. doi:10.1002/sim.1238.

    Article  Google Scholar 

  12. Moser BK, Stevens GR. Homogeneity of variance in the two-sample means test. Am Stat. 1992;46:19–21.

    Google Scholar 

  13. Ruxton GD. The unequal variance t-test is an underused alternative to Student’s t-test and the Mann–Whitney U test. Behav Ecol. 2006;17:688–90. doi:10.1093/beheco/ark016.

    Article  Google Scholar 

  14. US Food and Drug Administration. Statistical approaches establishing bioequivalence. 2001.

  15. Anon. Kinetica 5.0 User Manual Revision Number 1.00. Thermo Fisher Scientific Inc. 2008. p. 667.

Download references

Author information

Authors and Affiliations

  1. Fuglsang Pharma, Hiort Lorenzens Vej 6c st. tv., 6100, Haderslev, Denmark

    Anders Fuglsang

  2. BEBAC–Consultancy Services for Bioequivalence and Bioavailability Studies, Neubaugasse 36/11, 1070, Vienna, Austria

    Helmut Schütz

  3. Cooperative Clinical Drug Research and Development AG, Lindenallee 70, 15366, Hoppegarten, Germany

    Detlew Labes

Authors
  1. Anders Fuglsang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Helmut Schütz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Detlew Labes
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anders Fuglsang.

Electronic Supplementary Material

Below is the link to the electronic supplementary material.

ESM 1

(ODS 46 kb)

ESM 2

(R 2 kb)

ESM 3

(SAS 1 kb)

ESM 4

(TXT 0 kb)

ESM 5

(TXT 0 kb)

ESM 6

(TXT 0 kb)

ESM 7

(TXT 0 kb)

ESM 8

(TXT 1 kb)

ESM 9

(TXT 0 kb)

ESM 10

(TXT 18 kb)

ESM 11

(TXT 32 kb)

ESM 12

(TXT 32 kb)

ESM 13

(TXT 18 kb)

ESM 14

(TXT 18 kb)

ESM 15

(GIF 12 kb)

High resolution image

(TIFF 18 kb)

ESM 16

(GIF 12 kb)

High resolution image

(TIFF 17 kb)

ESM 17

(GIF 10 kb)

High resolution image

(TIFF 16 kb)

ESM 18

(GIF 12 kb)

High resolution image

(TIFF 18 kb)

ESM 19

(GIF 15 kb)

High resolution image

(TIFF 22 kb)

ESM 20

(GIF 15 kb)

High resolution image

(TIFF 21 kb)

ESM 21

(GIF 15 kb)

High resolution image

(TIFF 29 kb)

ESM 22

(GIF 23 kb)

High resolution image

(TIFF 63 kb)

ESM 23

(GIF 17 kb)

High resolution image

(TIFF 44 kb)

ESM 24

(GIF 15 kb)

High resolution image

(TIFF 29 kb)

ESM 25

(GIF 15 kb)

High resolution image

(TIFF 29 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fuglsang, A., Schütz, H. & Labes, D. Reference Datasets for Bioequivalence Trials in a Two-Group Parallel Design. AAPS J 17, 400–404 (2015). https://doi.org/10.1208/s12248-014-9704-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/s12248-014-9704-6

KEY WORDS

Search

Navigation